Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Tomoka Hisada"'
Autor:
Tomoka Hisada, Naoto Kondo, Yumi Wanifuchi-Endo, Satoshi Osaga, Takashi Fujita, Tomoko Asano, Yasuaki Uemoto, Sayaka Nishikawa, Yusuke Katagiri, Mitsuo Terada, Akiko Kato, Hiroshi Sugiura, Katsuhiro Okuda, Hiroyuki Kato, Masayuki Komura, Satoshi Morita, Satoru Takahashi, Tatsuya Toyama
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-13 (2022)
Abstract Lethal giant larvae homolog 2 (LLGL2) and solute carrier family 7 member 5 (SLC7A5) have been reported to be involved in resistance to endocrine therapy. This study aimed to assess the effects of LLGL2/SLC7A5 co-expression in predicting prog
Externí odkaz:
https://doaj.org/article/5a0a98b33db243219a69efe2841d6845
Autor:
Nana Matsumoto, Naoto Kondo, Yumi Wanifuchi-Endo, Tomoko Asano, Tomoka Hisada, Yasuaki Uemoto, Akiko Kato, Mitsuo Terada, Natsumi Yamanaka, Ayaka Isogai, Muneyuki Takayama, Takeshi Hasegawa, Koichi Ito, Keiji Mashita, Tatsuya Toyama
Publikováno v:
Surgical Case Reports, Vol 8, Iss 1, Pp 1-5 (2022)
Abstract Background Granulocyte colony-stimulating factor (G-CSF) is increasingly used to prevent chemotherapy-associated febrile neutropenia. Generally, aortitis is not considered a side effect of G-CSF and is thought to be extremely rare. Aortitis
Externí odkaz:
https://doaj.org/article/56c65ecb66cb40788e838c1d9f558aea
Autor:
Akiko Kato, Naoto Kondo, Yumi Wanifuchi-Endo, Takashi Fujita, Tomoko Asano, Tomoka Hisada, Yasuaki Uemoto, Mitsuo Terada, Tatsuya Toyama
Publikováno v:
Cancer Research. 82:P4-07
Background: Tubulointerstitial nephritis antigen-like 1 (Tinagl1) is reported to inhibit integrin and epidermal growth factor receptor (EGFR) and suppress tumor metastasis and growth in breast cancer. We investigated the association between Tinagl1 m
Publikováno v:
Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association). 83:1398-1402
Autor:
Akiko Kato, Naoto Kondo, Yumi Wanifuchi-Endo, Takashi Fujita, Tomoko Asano, Tomoka Hisada, Yasuaki Uemoto, Mitsuo Terada, Hiroyuki Kato, Masayuki Komura, Katsuhiro Okuda, Satoru Takahashi, Tatsuya Toyama
Publikováno v:
Journal of cancer research and clinical oncology.
Purpose: Tubulointerstitial nephritis antigen-like 1 (TINAGL1) was reported to suppress tumor metastasis and growth in triple-negative (TN) breast cancer. We aimed to determine the associations of TINAGL1 expression with clinicopathological factors a
Autor:
Mitsuo Terada, Naoto Kondo, Yumi Wanifuchi-Endo, Takashi Fujita, Tomoko Asano, Tomoka Hisada, Yasuaki Uemoto, Akiko Kato, Natsumi Yamanaka, Hiroshi Sugiura, Keiko Mita, Asaka Wada, Eriko Takahashi, Kanako Saito, Ryo Yoshioka, Tatsuya Toyama
Publikováno v:
Breast cancer research and treatment. 195(3)
PurposeVaccination is an essential strategy to prevent infection in the SARS-CoV-2 pandemic. However, there are concerns about vaccine efficacy and the impact of vaccination on cancer treatment. Additionally, the emergence of novel variants may affec
Autor:
Yasuaki Uemoto, Akiko Kato, Sayaka Nishikawa, Yu Dong, Naoto Kondo, Satoshi Osaga, Tomoka Hisada, Tatsuya Toyama, Hiroshi Sugiura, Yusuke Katagiri, Mitsuo Terada, Takashi Fujita, Hiroyuki Kato, Yumi Wanifuchi-Endo, Katsuhiro Okuda, Satoru Takahashi, Tomoko Asano, Tae-Sun Kim
Publikováno v:
Breast Cancer Research and Treatment. 187:81-93
Retinoic acid-induced 2 (RAI2) has been shown to be a putative suppressor of the early hematogenous dissemination of tumor cells to the bone marrow in breast cancer. Here, we investigated the associations of RAI2 mRNA and protein expression with clin
Autor:
Tomoko Asano, Yusuke Katagiri, Sayaka Nishikawa, Akiko Kato, Satoru Takahashi, Mitsuo Terada, Katsuhiro Okuda, Satoshi Morita, Hiroyuki Kato, Yasuaki Uemoto, Satoshi Osaga, Naoto Kondo, Tomoka Hisada, Hiroshi Sugiura, Yumi Wanifuchi-Endo, Takashi Fujita, Tatsuya Toyama, Masayuki Komura
Lethal giant larvae homolog 2 (LLGL2) and solute carrier family 7 member 5 (SLC7A5) have been reported to be involved in resistance to endocrine therapy. This study aimed to assess the effects of LLGL2/SLC7A5 co-expression in predicting prognosis and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b8a82cc7f5fa5fef9aad9eeee8c00831
https://doi.org/10.21203/rs.3.rs-984390/v1
https://doi.org/10.21203/rs.3.rs-984390/v1
Autor:
Yasuaki, Uemoto, Eriko, Katsuta, Naoto, Kondo, Yumi, Wanifuchi-Endo, Takashi, Fujita, Tomoko, Asano, Tomoka, Hisada, Mitsuo, Terada, Akiko, Kato, Katsuhiro, Okuda, Hiroshi, Sugiura, Masayuki, Komura, Hiroyuki, Kato, Satoshi, Osaga, Satoru, Takahashi, Tatsuya, Toyama
Publikováno v:
Am J Cancer Res
HECT domain E3 ubiquitin ligase 1 (HECTD1) has been reported to be a negative regulator of epithelial-mesenchymal transition and to decrease breast cancer invasion and metastasis. However, the clinical significance and detailed role of HECTD1 in brea
Autor:
Hiroyuki Kato, Naoto Kondo, Satoshi Morita, Yusuke Katagiri, Tomoka Hisada, Akiko Kato, Hiroshi Sugiura, Satoru Takahashi, Satoshi Osaga, Tomoko Asano, Katsuhiro Okuda, Mitsuo Terada, Takashi Fujita, Yumi Wanifuchi-Endo, Tatsuya Toyama, Masayuki Komura, Yasuaki Uemoto, Sayaka Nishikawa
Background Lethal giant larvae homolog 2 (LLGL2) functions as a promoter of tumor growth and localizes at cell junctions and membranes with solute carrier family 7 member 5 (SLC7A5) in estrogen receptor α (ERα)-positive breast cancer. LLGL2 and SLC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c52880d6d0311deeabb641f0e92e7058
https://doi.org/10.21203/rs.3.rs-728950/v1
https://doi.org/10.21203/rs.3.rs-728950/v1